Literature DB >> 19205775

Pioglitazone-induced heart failure in a patient with restrictive cardiomyopathy and metabolic myopathy.

Josef Finsterer1, Claudia Stöllberger.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19205775     DOI: 10.1007/s00392-009-0757-y

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


× No keyword cloud information.
  23 in total

Review 1.  [Heart conduction disorders in long-term treatment with chloroquine. Two new cases].

Authors:  C Verny; C de Gennes; P Sébastien; H D Lê Thi; C Chapelon; J C Piette; G Chomette; P Godeau
Journal:  Presse Med       Date:  1992 May 2-9       Impact factor: 1.228

2.  Desmin accumulation restrictive cardiomyopathy and atrioventricular block associated with desmin gene defects.

Authors:  Eloisa Arbustini; Michele Pasotti; Andrea Pilotto; Carlo Pellegrini; Maurizia Grasso; Stefano Previtali; Alessandra Repetto; Ornella Bellini; Gaetano Azan; Manuela Scaffino; Carlo Campana; Giovanni Piccolo; Mario Viganò; Luigi Tavazzi
Journal:  Eur J Heart Fail       Date:  2005-12-22       Impact factor: 15.534

Review 3.  Extracardiac medical and neuromuscular implications in restrictive cardiomyopathy.

Authors:  Claudia Stöllberger; Josef Finsterer
Journal:  Clin Cardiol       Date:  2007-08       Impact factor: 2.882

4.  Cardiomyopathy and multicore myopathy with accumulation of intermediate filaments.

Authors:  E Bertini; C Bosman; M Bevilacqua; E Ricci; G M Gagliardi; F Parisi; S Servidei; C Dionisi-Vici; L Ballerini
Journal:  Eur J Pediatr       Date:  1990-09       Impact factor: 3.183

5.  Desmin myopathy involving cardiac, skeletal, and vascular smooth muscle: report of a case with immunoelectron microscopy.

Authors:  S C Abraham; D DeNofrio; E Loh; J M Minda; J E Tomaszewski; G G Pietra; C Reynolds
Journal:  Hum Pathol       Date:  1998-08       Impact factor: 3.466

6.  Restrictive cardiomyopathy associated with the eosinophilia-myalgia syndrome.

Authors:  P B Berger; J Duffy; G S Reeder; B L Karon; W D Edwards
Journal:  Mayo Clin Proc       Date:  1994-02       Impact factor: 7.616

7.  [Restrictive cardiomyopathy due to myofibrillar myopathy].

Authors:  I Ligi; A Fraisse; B Chabrol; O Paut; F Bourlon; D Métras; J L Bonnet; J F Pellissier
Journal:  Arch Pediatr       Date:  2003-05       Impact factor: 1.180

8.  Impact of pioglitazone on coronary endothelial function in non-diabetic patients with coronary artery disease.

Authors:  Jochen Wöhrle; Nikolaus Marx; Wolfgang Koenig; Vinzenz Hombach; Hans A Kestler; Martin Höher; Thorsten Nusser
Journal:  Clin Res Cardiol       Date:  2008-04-24       Impact factor: 5.460

9.  Restrictive cardiomyopathy caused by chloroquine.

Authors:  G Iglesias Cubero; J J Rodriguez Reguero; J M Rojo Ortega
Journal:  Br Heart J       Date:  1993-05

Review 10.  [Therapy with glitazones--a risk for cardiovascular disease?].

Authors:  D Rottlaender; G Michels; E Erdmann; U C Hoppe
Journal:  Dtsch Med Wochenschr       Date:  2007-12       Impact factor: 0.628

View more
  1 in total

1.  Diagnostic superiority of a combined assessment of the systolic and early diastolic mitral annular velocities by tissue Doppler imaging for the differentiation of restrictive cardiomyopathy from constrictive pericarditis.

Authors:  Thomas Butz; C Piper; C Langer; M Wiemer; T Kottmann; A Meissner; G Plehn; H J Trappe; D Horstkotte; L Faber
Journal:  Clin Res Cardiol       Date:  2010-01-06       Impact factor: 5.460

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.